Drug Price Trends for NDC 72241-0009

Average Pharmacy Cost for 72241-0009

Drug Name	NDC	Price/Unit ($)	Unit	Date
FLUOXETINE HCL 40 MG CAPSULE	72241-0009-10	0.06815	EACH	2025-03-19
FLUOXETINE HCL 40 MG CAPSULE	72241-0009-10	0.06602	EACH	2025-02-19
FLUOXETINE HCL 40 MG CAPSULE	72241-0009-10	0.05872	EACH	2025-01-22
FLUOXETINE HCL 40 MG CAPSULE	72241-0009-10	0.05938	EACH	2024-12-18

Best Wholesale Price for NDC 72241-0009

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for NDC 72241-0009

The pharmaceutical industry is constantly evolving, with market dynamics shifting due to various factors such as technological advancements, regulatory changes, and economic conditions. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug associated with National Drug Code (NDC) 72241-0009, providing valuable insights for industry professionals and stakeholders.

Understanding NDC 72241-0009

NDC 72241-0009 is associated with a specific drug product in the United States. The National Drug Code (NDC) is a unique, three-segment number assigned by the Food and Drug Administration (FDA) to human drugs in the United States[9]. It serves as a universal product identifier for human drugs and plays a crucial role in various aspects of the pharmaceutical supply chain.

Drug Identification

The NDC 72241-0009 corresponds to a drug manufactured by Modavar Pharmaceuticals LLC[1]. While the specific drug name is not provided in the search results, we can infer that it is likely a prescription medication, given the manufacturer's involvement in producing various pharmaceutical products.

Market Trends Affecting NDC 72241-0009

Technological Advancements

The pharmaceutical industry is experiencing rapid technological advancements, particularly in areas such as artificial intelligence (AI), gene editing, and big data analytics. These innovations are transforming drug development processes, potentially reducing costs and time-to-market for new medications[3].

"AI, gene editing, and big data analytics are transforming the pharmaceutical industry, reducing development time and costs."[3]

For NDC 72241-0009, these advancements could lead to:

1. Improved manufacturing processes
2. Enhanced drug efficacy through targeted therapies
3. More efficient clinical trials

Personalized Medicine

The trend towards personalized medicine is gaining momentum, with treatments increasingly tailored to individual genetic profiles. This shift could significantly impact the market positioning and pricing strategy for NDC 72241-0009, depending on its therapeutic area and potential for personalization[3].

Regulatory Environment

The regulatory landscape for pharmaceuticals is continually evolving. Recent changes in FDA regulations and the potential impact of new government policies could affect the market dynamics for NDC 72241-0009[9].

Key regulatory considerations include:

1. FDA approval processes
2. Compliance with updated labeling requirements
3. Potential changes in drug pricing policies

Price Projections for NDC 72241-0009

While specific price data for NDC 72241-0009 is not available in the search results, we can analyze general pricing trends in the pharmaceutical industry to make informed projections.

Factors Influencing Price

Several factors are likely to influence the pricing of NDC 72241-0009:

1. Competition: The presence of generic alternatives or biosimilars could exert downward pressure on prices.
2. Patent Status: If NDC 72241-0009 is a branded drug nearing patent expiration, it may face pricing challenges in the near future.
3. Manufacturing Costs: Technological advancements could potentially reduce production costs, influencing pricing strategies.
4. Demand: Changes in disease prevalence or treatment guidelines could affect demand and, consequently, pricing.

Pricing Pressures

The pharmaceutical industry is facing significant pricing pressures, with nearly half of C-suite executives expecting pricing and access issues to significantly affect their strategies in 2025[3].

"Pricing and access to drugs remain significant issues for the life sciences industry. Nearly half of C-suite executives surveyed expect pricing and access to significantly affect their strategies in 2025."[3]

Potential Pricing Scenarios

Based on industry trends, we can project three potential pricing scenarios for NDC 72241-0009:

1. Stable Pricing: If the drug maintains a strong market position and faces limited competition, prices may remain relatively stable.
2. Moderate Decrease: Increasing competition or pricing pressures could lead to a gradual decrease in price over time.
3. Significant Decrease: If NDC 72241-0009 faces generic competition or loses patent protection, it could experience a more substantial price reduction.

Market Positioning Strategies

To navigate the evolving market landscape, manufacturers of NDC 72241-0009 may consider the following strategies:

Differentiation Through Innovation

Investing in research and development to enhance the drug's efficacy or expand its indications could help maintain its market position and justify its pricing.

Value-Based Pricing

Implementing value-based pricing models that tie the drug's cost to its clinical outcomes could help address pricing pressures while demonstrating its value to payers and patients.

Strategic Partnerships

Collaborating with other pharmaceutical companies or technology firms could lead to synergies in drug development, manufacturing, or distribution, potentially reducing costs and improving market access.

Impact of Industry Trends on NDC 72241-0009

Immunology and Inflammation Sector Growth

The immunology and inflammation (I&I) sector is expected to see continued growth in 2025, driven by advancements in understanding immune system mechanisms and the development of targeted therapies[7]. If NDC 72241-0009 is related to this therapeutic area, it could benefit from increased investment and research interest.

Mergers and Acquisitions

The pharmaceutical industry is likely to see increased merger and acquisition (M&A) activity as companies seek to maintain market share in the face of patent expirations[3]. This trend could potentially affect the ownership or distribution of NDC 72241-0009.

Artificial Intelligence in Drug Development

The integration of AI in drug development processes could significantly impact the lifecycle of NDC 72241-0009, from research and development to manufacturing and marketing[3].

Consumer Impact and Market Access

Understanding the potential impact of NDC 72241-0009 on consumers is crucial for projecting its market performance and pricing strategy.

Affordability Challenges

High prescription drug prices continue to create affordability challenges for patients and the healthcare system[4]. The pricing strategy for NDC 72241-0009 will need to balance profitability with accessibility to ensure market success.

Patient-Centric Approaches

Implementing patient-centric approaches, such as patient assistance programs or innovative pricing models, could help improve market access and patient outcomes for NDC 72241-0009.

Future Outlook and Market Projections

Looking ahead to 2025 and beyond, several factors are likely to shape the market landscape for NDC 72241-0009:

Technological Integration

The continued integration of AI, big data analytics, and other advanced technologies is expected to revolutionize drug development and manufacturing processes[3]. This could potentially lead to more efficient production and improved efficacy for NDC 72241-0009.

Regulatory Changes

Potential changes in healthcare policies and regulations, particularly those related to drug pricing and approval processes, could significantly impact the market dynamics for NDC 72241-0009[9].

Global Market Expansion

The global biotech market is projected to expand from $483.0 billion in 2024 to $546.0 billion by 2025, reflecting a robust compound annual growth rate (CAGR) of approximately 13%[7]. This growth could present new opportunities for NDC 72241-0009, particularly if it can demonstrate strong efficacy and value.

Key Takeaways

1. NDC 72241-0009 is a drug product manufactured by Modavar Pharmaceuticals LLC, likely a prescription medication.
2. Technological advancements, particularly in AI and personalized medicine, are reshaping the pharmaceutical landscape and could impact the development and marketing of NDC 72241-0009.
3. Pricing pressures and regulatory changes are significant factors that will influence the pricing strategy and market access for NDC 72241-0009.
4. The immunology and inflammation sector is expected to see continued growth, which could benefit NDC 72241-0009 if it falls within this therapeutic area.
5. Implementing value-based pricing models and patient-centric approaches could help address affordability challenges and improve market access.
6. The global biotech market is projected to grow significantly, presenting potential opportunities for expansion and innovation.

FAQs

1. What is the significance of the National Drug Code (NDC)? The NDC is a unique identifier assigned by the FDA to human drugs in the United States. It plays a crucial role in tracking and managing drug products throughout the supply chain.

2. How might technological advancements impact the pricing of NDC 72241-0009? Technological advancements could potentially reduce manufacturing costs and improve drug efficacy, which could influence pricing strategies. However, the exact impact would depend on the specific nature of the drug and its production process.

3. What strategies can pharmaceutical companies employ to address pricing pressures? Companies can consider value-based pricing models, strategic partnerships, and investment in innovation to differentiate their products and justify pricing in a competitive market.

4. How might the trend towards personalized medicine affect NDC 72241-0009? If NDC 72241-0009 can be tailored for personalized treatments based on genetic profiles, it could potentially command a premium price and maintain a strong market position.

5. What role does regulatory compliance play in the market performance of NDC 72241-0009? Regulatory compliance is crucial for maintaining market access and avoiding potential fines or restrictions. Staying up-to-date with FDA regulations and adapting to policy changes is essential for the long-term success of NDC 72241-0009.

Sources cited: [1] https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0f73074-f3d8-4812-8e64-f88a02869ed3 [3] https://www.pwc.com/us/en/industries/pharma-life-sciences/pharmaceutical-industry-trends.html [4] https://aspe.hhs.gov/sites/default/files/documents/e9d5bb190056eb94483b774b53d512b4/price-tracking-brief.pdf [7] https://www.labiotech.eu/in-depth/biotech-trends-2025/ [9] https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory